Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00910052 · ClinicalTrials.gov registry record · NA
Fibrin Sealant in Renal Transplantation
A NA study, sponsored by Hennepin County Medical Center, Minneapolis.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
NCT00910052: Completed NA study, sponsored by Hennepin County Medical Center, Minneapolis.
NCT00910052 is a NA study that has completed, run by Hennepin County Medical Center, Minneapolis. The registered enrollment target is 141 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00910052, a NA study, has completed, sponsored by Hennepin County Medical Center, Minneapolis.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
Study Summary
Background: Post-operative wound complications arise in as many as 50% of kidney transplant recipients. Fibrin sealants have been used in many areas of surgery in attempt to reduce the accumulation of post-operative fluid collections with varying success. The use of fibrin products has been proposed as a means of reducing local wound complications in the immunocompromised renal transplant recipient but as yet has not been studied. Methods: 145 patients were enrolled and 141 patients were randomized (74 Tisseelä fibrin sealant, 67 No Tisseelä fibrin sealant) in a prospective manner to receive fibrin sealant or not at the time of their renal transplant. Patients were analyzed per the randomization assignment. The operating team was blinded to the decision until after the iliac fossa dissection was complete. The sealant was applied via aerosol to the iliac fossa and renal allograft hilum after completion of the neoureterocystostomy in 5 ml quantity. Clinical and radiographic data were reviewed through the usual 8-week follow-up transplant ultrasound. Patients in whom the peritoneum was entered were excluded from data analysis. The incidence of lymphocele, wound infection, dehiscence, clinically significant hematoma as defined by necessitating incision and drainage, and urine leak was recorded.
Interventions
- DEVICE Tisseelä fibrin sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2003-05 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT00910052 record still lists
NCT00910052 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Tisseelä fibrin sealant is the first listed.
NCT00910052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00910052 about?
NCT00910052 is a clinical study titled "Fibrin Sealant in Renal Transplantation". Background: Post-operative wound complications arise in as many as 50% of kidney transplant recipients. Fibrin sealants have been used in many areas of surgery in attempt to reduce the accumulation of post-operative fluid collections with varying success. The use of fibrin products has been proposed...
What is the current status of trial NCT00910052?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2003-05. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00910052?
The interventions under investigation include: Tisseelä fibrin sealant (DEVICE).
Who is sponsoring clinical trial NCT00910052?
This trial is sponsored by Hennepin County Medical Center, Minneapolis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00910052's enrollment target sits among peer trials
141 712th of 2000 higher than 1,288 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia